Evidence map›Paper›PMID 41684008›Full record

ArticleInternational journal of molecular sciences2026

Composition of Human Meibomian Gland Secretions: Insights from TOF-SIMS Analysis.

Katarzyna Balin, Beata Węglarz, Karol Dobiczek, Dorota Tarnawska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katarzyna BalinA. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1A, 41-500 Chorzów, Poland.ORCID 0000-0002-1811-3033
Beata WęglarzClinical Department of Ophthalmology, District Railway Hospital, Panewnicka 65, 40-760 Katowice, Poland.
Karol DobiczekDepartment of Human-Centered Artificial Intelligence, Institute of Applied Computer Science, Jagiellonian University, Łojasiewicza 11, 30-348 Krakow, Poland.
Dorota TarnawskaClinical Department of Ophthalmology, District Railway Hospital, Panewnicka 65, 40-760 Katowice, Poland.ORCID 0000-0002-0520-9589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the efficacy of the TOF-SIMS (time-of-flight secondary ion mass spectrometry) technique for the comprehensive lipidomic analysis of human meibum, a lipid-rich secretion essential for tear film stability, using samples collected from ten participants. The applied methodology proved effective in characterizing the complex chemistry of meibum, confirming the presence of diverse lipid classes, including fatty acids, sterols, and glycerolipids. Multivariate and pairwise statistical analyses, including permutational multivariate analysis of variance (PERMANOVA) and maximum mean discrepancy (MMD),confirmed the significant compositional difference between the two groups. Principal component analysis (PCA) revealed a clear separation between the samples, driven primarily by an elevated ratio of monounsaturated fatty acids (C18:1, C16:1) to cholesterol in the group with MGD compared to healthy controls. These findings demonstrate the utility of TOF-SIMS coupled with multivariate analysis for detecting disease-specific molecular alterations in meibum, highlighting its potential for differentiating ocular surface pathologies.

Indexed as

LipidsMeibomian GlandsSpectrometry, Mass, Secondary IonAdultFatty AcidsFemaleHumansLipidomicsMaleMiddle AgedPrincipal Component AnalysisTearsFatty AcidsLipidslipid analysismass spectroscopymeibomian gland secretionsmeibumPCATOF-SIMS

Identifiers

PMID41684008
PMCPMC12898181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.